The translocation t(11;14)(q13;q32) is the genetic hallmark of mantle cell lymphoma (MCL) but is not sufficient for inducing lymphomagenesis. Here we performed genome-wide 100K GeneChip Mapping in 26 t(11;14)-positive MCL and six MCL cell lines. Partial uniparental disomy (pUPD) was shown to be a recurrent chromosomal event not only in MCL cell lines but also in primary MCL. Remarkably, pUPD affected recurrent targets of deletion like 11q, 13q and 17p. Moreover, we identified 12 novel regions of recurrent gain and loss as well as 12 high-level amplifications and eight homozygously deleted regions hitherto undescribed in MCL. Interestingly, GeneChip analyses identified different genes, encoding proteins involved in microtubule dynamics, such...
International audienceMantle cell lymphoma (MCL) is a lymphoproliferative disorder characterized by ...
Mantle cell lymphoma (MCL), an aggressive subtype of non-Hodgkin lymphoma, is characterized by the h...
Mantle cell lymphoma (MCL) is genetically characterized by 11q13 translocations leading to the overe...
The translocation t(11;14)(q13;q32) is the genetic hallmark of mantle cell lymphoma (MCL) but is not...
Contains fulltext : 47523.pdf (publisher's version ) (Closed access)Mantle cell ly...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
OBJECTIVE: Mantle cell lymphoma (MCL) is a lymphoma characterized by aberrant activation of CCND1...
Mantle cell lymphoma (MCL) is a distinct subentity of non-Hodgkin lymphoma, characterized by the chr...
Contains fulltext : 69686.pdf (publisher's version ) (Closed access)Mantle cell ly...
Mantle cell lymphoma (MCL) is a rare, aggressive and incurable type of cancer with a high incidence ...
Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translo...
Contains fulltext : 50323.pdf (publisher's version ) (Closed access)The molecular ...
To identify recurrent genomic changes in mantle cell lymphoma (MCL), we used high-resolution compara...
The genome of mantle cell lymphoma (MCL) is, in addition to the translocation t(11;14), characterize...
Mantle cell lymphoma (MCL) is an aggressive disease, with variable clinical course and heterogenous ...
International audienceMantle cell lymphoma (MCL) is a lymphoproliferative disorder characterized by ...
Mantle cell lymphoma (MCL), an aggressive subtype of non-Hodgkin lymphoma, is characterized by the h...
Mantle cell lymphoma (MCL) is genetically characterized by 11q13 translocations leading to the overe...
The translocation t(11;14)(q13;q32) is the genetic hallmark of mantle cell lymphoma (MCL) but is not...
Contains fulltext : 47523.pdf (publisher's version ) (Closed access)Mantle cell ly...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
OBJECTIVE: Mantle cell lymphoma (MCL) is a lymphoma characterized by aberrant activation of CCND1...
Mantle cell lymphoma (MCL) is a distinct subentity of non-Hodgkin lymphoma, characterized by the chr...
Contains fulltext : 69686.pdf (publisher's version ) (Closed access)Mantle cell ly...
Mantle cell lymphoma (MCL) is a rare, aggressive and incurable type of cancer with a high incidence ...
Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11;14)(q13;q32) translo...
Contains fulltext : 50323.pdf (publisher's version ) (Closed access)The molecular ...
To identify recurrent genomic changes in mantle cell lymphoma (MCL), we used high-resolution compara...
The genome of mantle cell lymphoma (MCL) is, in addition to the translocation t(11;14), characterize...
Mantle cell lymphoma (MCL) is an aggressive disease, with variable clinical course and heterogenous ...
International audienceMantle cell lymphoma (MCL) is a lymphoproliferative disorder characterized by ...
Mantle cell lymphoma (MCL), an aggressive subtype of non-Hodgkin lymphoma, is characterized by the h...
Mantle cell lymphoma (MCL) is genetically characterized by 11q13 translocations leading to the overe...